Literature DB >> 7812605

Infection by HIV-1 blocked by binding of dextrin 2-sulphate to the cell surface of activated human peripheral blood mononuclear cells and cultured T-cells.

S Shaunak1, N J Gooderham, R J Edwards, N Payvandi, C M Javan, N Baggett, J MacDermot, J N Weber, D S Davies.   

Abstract

1. Structural analogues of a sulphated polysaccharide, dextrin sulphate, were synthesized and tested for their ability to block infection by HIV-1. Using the T-cell lines, C8166 and HPB-ALL, and the laboratory adapted strains of HIV-1.MN, HIV-1.IIIb and HIV-1.RF, dextrin 2-sulphate (D2S) combined the best combination of high anti-HIV-1 activity (95% inhibitory concentration (IC95) = 230 nM) and low anticoagulant activity. It also blocked infection of activated peripheral blood mononuclear (PBMN) cells by five primary viral isolates at an IC95 of 230-3700 nM depending upon the primary viral isolate tested. 2. In saturation binding studies, [3H]-D2S bound to a cell surface protein on HPB-ALL cells in a specific and saturable manner with a Kd of 82 +/- 14 nM and a Bmax of 4.8 +/- 0.3 pmol/10(6) cells. It bound to other human T-cell lines in a similar manner. 3. There was very little binding of [3H]-D2S to freshly isolated PBMN cells (Bmax 0.18 +/- 0.03 pmol/10(6) cells) and these cells could not be infected by HIV-1. Culture of PBMN cells in lymphocyte growth medium (LGM) containing IL-2 did not significantly change the Bmax of [3H]-D2S. In contrast, PBMN cells which had been cultured with phytohaemagglutinin (PHA; 5 micrograms ml-1) for 72 h had a Bmax of [3H]-D2S binding of 7.2 +/- 0.1 pmol/10(6) cells and these cells could be infected by HIV-1. Removal of the PHA and further culture of the PBMN cells in LGM containing IL-2 resulted in a fall in the Bmax to 2.0 +/- 0.1 pmol/10(6) cells. The Kd of binding did not change significantly during the course of these experiments.4. [3H]-D2S did not bind to freshly isolated erythrocytes or to erythrocytes which had been cultured in PHA for 72 h.5. These results suggest that there is a relationship between the expression of the [3H]-D2S binding protein on the plasma membrane of PBMN cells and the susceptibility of these cells to infection by HIV- 1.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7812605      PMCID: PMC1510045          DOI: 10.1111/j.1476-5381.1994.tb16187.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  39 in total

1.  CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA.

Authors:  G E FOLEY; H LAZARUS; S FARBER; B G UZMAN; B A BOONE; R E MCCARTHY
Journal:  Cancer       Date:  1965-04       Impact factor: 6.860

2.  Kinetics of the HIV-CD4 interactions and virus-cell fusion.

Authors:  P J Klasse; J P Moore
Journal:  AIDS       Date:  1992-03       Impact factor: 4.177

3.  Two E-rosette-forming lymphoid cell lines.

Authors:  S Morikawa; E Tatsumi; M Baba; T Harada; K Yasuhira
Journal:  Int J Cancer       Date:  1978-02-15       Impact factor: 7.396

Review 4.  Sulfates of the simple sugars.

Authors:  J R Turvey
Journal:  Adv Carbohydr Chem Biochem       Date:  1965       Impact factor: 12.200

5.  Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. The NIH/NIAID/DAIDS/ACTG Virology Laboratories.

Authors:  F B Hollinger; J W Bremer; L E Myers; J W Gold; L McQuay
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

6.  The effects of high-dose recombinant soluble CD4 on human immunodeficiency virus type 1 viremia.

Authors:  T Schacker; R W Coombs; A C Collier; J E Zeh; I Fox; J Alam; K Nelson; E Eggert; L Corey
Journal:  J Infect Dis       Date:  1994-01       Impact factor: 5.226

7.  Restricted expression of human T-cell leukemia--lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes.

Authors:  S Z Salahuddin; P D Markham; F Wong-Staal; G Franchini; V S Kalyanaraman; R C Gallo
Journal:  Virology       Date:  1983-08       Impact factor: 3.616

8.  Mechanisms of immune activation of human immunodeficiency virus in monocytes/macrophages.

Authors:  R D Schrier; J A McCutchan; C A Wiley
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

9.  Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix.

Authors:  W F SCHERER; J T SYVERTON; G O GEY
Journal:  J Exp Med       Date:  1953-05       Impact factor: 14.307

10.  Possible role for cell-surface carbohydrate-binding molecules in lymphocyte recirculation.

Authors:  L M Stoolman; S D Rosen
Journal:  J Cell Biol       Date:  1983-03       Impact factor: 10.539

View more
  9 in total

Review 1.  Surrogacy in antiviral drug development.

Authors:  Sunil Shaunak; Donald S Davies
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

2.  The appealing story of HIV entry inhibitors : from discovery of biological mechanisms to drug development.

Authors:  Antonella Castagna; Priscilla Biswas; Alberto Beretta; Adriano Lazzarin
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Anti-Kaposi's sarcoma and antiangiogenic activities of sulfated dextrins.

Authors:  M Thornton; L Barkley; J C Mason; S Shaunak
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

4.  Polyvalent side chain peptide-synthetic polymer conjugates as HIV-1 entry inhibitors.

Authors:  Maarten Danial; Michael J Root; Harm-Anton Klok
Journal:  Biomacromolecules       Date:  2012-04-27       Impact factor: 6.988

5.  Candidate polyanionic microbicides inhibit human T-cell lymphotropic virus type 1 receptor interactions, cell-free infection, and cell-cell spread.

Authors:  Daniela Romer; David W Brighty; Cynthia L Robson; Quentin J Sattentau
Journal:  Antimicrob Agents Chemother       Date:  2008-12-01       Impact factor: 5.191

6.  Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum.

Authors:  Joshua D Nosanchuk; Judith N Steenbergen; Li Shi; George S Deepe; Arturo Casadevall
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

7.  Candidate polyanion microbicides inhibit HIV-1 infection and dissemination pathways in human cervical explants.

Authors:  Patricia S Fletcher; Gregory S Wallace; Pedro M M Mesquita; Robin J Shattock
Journal:  Retrovirology       Date:  2006-08-01       Impact factor: 4.602

8.  Anti-HIV-1 activity of anionic polymers: a comparative study of candidate microbicides.

Authors:  A Robert Neurath; Nathan Strick; Yun-Yao Li
Journal:  BMC Infect Dis       Date:  2002-11-21       Impact factor: 3.090

9.  Cellulose acetate phthalate, a common pharmaceutical excipient, inactivates HIV-1 and blocks the coreceptor binding site on the virus envelope glycoprotein gp120.

Authors:  A R Neurath; N Strick; Y Y Li; A K Debnath
Journal:  BMC Infect Dis       Date:  2001-09-25       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.